Belvedere Trading LLC Acquires New Position in Enfusion, Inc. (NYSE:ENFN)

Belvedere Trading LLC bought a new position in shares of Enfusion, Inc. (NYSE:ENFN) during the 3rd quarter, Holdings Channel reports. The firm bought 12,041 shares of the company’s stock, valued at approximately $114,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in ENFN. Scalar Gauge Management LLC boosted its position in shares of Enfusion by 21.8% in the 2nd quarter. Scalar Gauge Management LLC now owns 613,513 shares of the company’s stock worth $5,227,000 after buying an additional 110,000 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in shares of Enfusion by 167.6% in the second quarter. Renaissance Technologies LLC now owns 97,100 shares of the company’s stock valued at $827,000 after purchasing an additional 60,811 shares in the last quarter. Susquehanna Fundamental Investments LLC acquired a new stake in shares of Enfusion in the first quarter valued at approximately $122,000. Squarepoint Ops LLC purchased a new position in shares of Enfusion during the 2nd quarter worth approximately $683,000. Finally, SG Americas Securities LLC purchased a new position in shares of Enfusion during the 3rd quarter worth approximately $892,000. 81.05% of the stock is currently owned by institutional investors and hedge funds.

Enfusion Stock Performance

ENFN stock opened at $8.72 on Tuesday. The stock’s 50 day moving average price is $8.76 and its 200 day moving average price is $8.84. The firm has a market cap of $1.12 billion, a P/E ratio of 218.00, a PEG ratio of 2.47 and a beta of 0.93. Enfusion, Inc. has a 1 year low of $7.52 and a 1 year high of $10.45.

Enfusion (NYSE:ENFN) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $0.02 EPS for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.01). The company had revenue of $49.46 million for the quarter, compared to analysts’ expectations of $50.27 million. Enfusion had a return on equity of 6.17% and a net margin of 1.98%. On average, research analysts predict that Enfusion, Inc. will post 0.07 earnings per share for the current year.

Enfusion Company Profile

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.